~~<i id='352792F11E'><strike id='352792F11E'><tt id='352792F11E'><pre id='352792F11E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

hotspot

author：leisure time 2025-09-30 20:05:52 - browse：64

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Congress may force more Covid

hotspot

Wikipedia

focus

explore

focus

AdobeRingTherapeutics,agenetherapystartuplaunchedbyFlagshipPioneering,haslaidoffjustunder20%ofitssta

WSS

As AI regulations shape up, health tech startups beg for clarity

As AI regulations shape up, health tech startups beg for clarity

Weight loss drugs aren’t covered by Obamacare. That may change

Kellogg’s is going to war over Mexico’s nutrition label rules

How the drug

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

entertainment

hotspot

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Abortion policy in the spotlight at Republican debate

New air purifier tech could be key to improving indoor air quality

Surprise medical billing ban raises prices elsewhere

The cancer drug shortage isn’t new — and neither are the solutions

Medicare Advantage enrollment grows 7.1% to 33.4 million people

New air purifier tech could be key to improving indoor air quality

Trans patients at the end of life deserve respect and dignity

Supreme Court strikes down use of affirmative action

How the first Native Hawaiian psychiatrist helped diversify medicine

Wikipedia

Intellia plays down concerns on accidental germline transmission

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Study: Spinal cord stimulation helps patients with paralysis walk again

Vivek Ramaswamy made waves in the debate, much as in biotech

A new drug could help frostbite victims avoid its ravages

Wikipedia

focus

explore

focus